We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

PIramed and Genentech Collaborate to Develop Anti-Cancer Drugs

PI 3-kinase inhibitors have the potential to treat a range of common tumours.
News

IDT Extends the Operating Schedule at its Oligonucleotide Production Center

The new schedule enables biotech researchers to order their products later each day.
News

Genomatix Achieves GeneChip-compatible™ Status with Affymetrix GeneChip® Microarray Platform

Genomatix is committed to integrating its entire microarray analysis pipeline with the Affymetrix technology.
News

Genetix Group Announces Directorate Change

Trevor Bell, Chief Operating Officer, will be resigning from the Board.
News

Chemicon Enters into License Agreement with RheoGene

Chemicon accesses the RheoGene's RheoSwitch® technology that regulates the timing and level of gene expression.
News

Agencourt Bioscience Enters Into Supply Agreement with Affymetrix

Agencourt RNAClean to be included in the reagent kit for Affymetrix' GeneChip® Array Station.
News

Affitech and XOMA Sign Antibody Collaboration and Cross-License Agreement

Affitech receives a license to use XOMA's bacterial cell expression technology for developing antibody products.
News

ACD/Labs and Protasis Announce Collaboration

The collaboration will offer a complete high-throughput system for NMR.
News

Agilent Technologies Acquires Molecular Imaging

This acquisition will strengthen Agilent's nanomeasurements portfolio.
News

Study Confirms Utility of Marillion’s Nanoparticle Technology for Tumor Targeting Agents

Findings describe how natural nanoparticles can be adapted to fight cancer.
Advertisement